⌘K

Login Start Free

Home/Filings/4/0001628280-23-042490

4//SEC Filing

Chan Mitchell 4

Accession 0001628280-23-042490

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 4:01 PM ET

Size

5.5 KB

Accession

0001628280-23-042490

Insider Transaction Report

Form 4

Period: 2023-12-20

Avalo Therapeutics, Inc.AVTX

Director

Transactions

Award
Stock Option (Right to Buy)
2023-12-20+3,334→ 3,334 total
Exercise: $0.04From: 2024-12-20Exp: 2033-12-20→ Common Stock (3,334 underlying)

Footnotes (1)

[F1]The stock option will vest in full on December 20, 2024, subject to the Reporting Person's continued service on such vesting date.

Documents

1 file

4
wk-form4_1703192494.xmlPrimary
FORM 4

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001789335

Filing Metadata

Form type: 4
Filed: Dec 20, 7:00 PM ET
Accepted: Dec 21, 4:01 PM ET
Size: 5.5 KB

View on SEC.gov